(Q36942675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Izabella Rzepka-Górska

series ordinal

2

object named as

Izabella Rzepka-Górska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

Contemporary oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

520-525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells

3 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Potent antibody drug conjugates for cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Anti-CD30 diabody-drug conjugates with potent antitumor activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Role of apoptotic and necrotic cell death under physiologic conditions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Deciphering CD30 ligand biology and its role in humoral immunity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Morphological and biochemical aspects of apoptosis, oncosis and necrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Structure and expression of murine CD30 and its role in cytokine production

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687467

Soluble CD30 in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women

4 September 2018

1 reference

12 December 2020

CD30: expression and function in health and disease

1 reference

12 December 2020

CD30: cytokine-receptor, differentiation marker or a target molecule for specific immune response?

1 reference

12 December 2020

[Concentration of soluble ligand for receptor CD30 (sCD30L)--marker of apoptosis in women with ovarian tumor]

1 reference

12 December 2020

Cytokeratin and CD30 expression in dysgerminoma

1 reference

12 December 2020

Expression of CD30 ligand (CD153) on murine activated T cells

1 reference

12 December 2020

CD30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th17 Responses

1 reference

12 December 2020

Identifiers

DOI

10.5114/WO.2012.32485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

23788939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23788939%20AND%20SRC:MED&resulttype=core&format=json